Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABERCROMBIE & FITCH CO /DE/ANF · Entity 3771 | Director | August 03, 2026 | August 04, 2026 |
| LABCORP HOLDINGS INC.LH · Entity 1277 | Director | August 17, 2026 | August 18, 2026 |
| SHERWIN WILLIAMS COSHW · Entity 2948 | Director | October 02, 2026 | October 06, 2026 |
| WORTHINGTON ENTERPRISES, INC.WOR · Entity 4282 | Director | September 23, 2025 | September 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABERCROMBIE & FITCH CO /DE/
Report date August 03, 2026 · Filed August 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 4,220.522 |
Reported balance
After 2026-08-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-03 · Grant · Acquired 91.044 · Balance 4,220.522 F1: Each share of phantom stock represents a right to receive one share of Issuer's common stock. F2: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock represents a right to receive one share of Issuer's common stock.
F2: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.
LABCORP HOLDINGS INC.
Report date August 17, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,563 |
Reported balance
After 2026-08-17 transaction · row 1
1 source rowRow 1 · 2026-08-17 · Sale · Disposed 3,000 · Balance 6,563 F1: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. |
| Common StockSEC Table I · non-derivative | IndirectBy Alexa M. Anderson Separate Trust | 144 |
Reported balance
Holding disclosure · report date 2026-08-17 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 144 |
| Common StockSEC Table I · non-derivative | IndirectBy Cameron Taff Anderson Separate Trust | 144 |
Reported balance
Holding disclosure · report date 2026-08-17 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 144 |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
SHERWIN WILLIAMS CO
Report date October 02, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectDeferred Fee Plan | 1,109.95 |
Reported balance
After 2026-10-02 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-10-02 · Grant · Acquired 30.85 · Balance 1,109.95 F1: Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company. F2: Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account. F3: These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan. |
| Common StockSEC Table I · non-derivative | Direct | 5,819 |
Reported balance
Holding disclosure · report date 2026-10-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 5,819 F4: No transaction is being reported on this line. Reported on a previously filed Form 4. F5: These securities consist of 1,100 restricted stock units ("RSUs") and 4,719 shares of common stock. Each RSU represents the Reporting Person's right to receive one share of common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company.
F2: Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account.
F3: These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.
F4: No transaction is being reported on this line. Reported on a previously filed Form 4.
F5: These securities consist of 1,100 restricted stock units ("RSUs") and 4,719 shares of common stock. Each RSU represents the Reporting Person's right to receive one share of common stock.
WORTHINGTON ENTERPRISES, INC.
Report date September 23, 2025 · Filed September 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 76,659 |
Reported balance
After 2026-09-24 transaction · row 1
1 source rowRow 1 · 2026-09-24 · Grant · Acquired 2,510 · Balance 76,659 F1: An award of restricted stock was granted pursuant to the Worthington Enterprises, Inc. 2025 Equity Plan for Non-Employee Directors. The restricted stock will vest on the earlier to occur of (1) the first anniversary of the grant date; or (2) the date on which the next Annual Meeting of Shareholders of Worthington Enterprises, Inc. is held. |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 12,822.05 |
Reported balance
After 2026-09-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-23 · Grant · Acquired 192.63 · Balance 12,822.05 F2: The theoretical WOR common shares ("phantom stock") credited to the reporting person's account in the Worthington Industries, Inc. Amended and Restated 2005 Deferred Compensation Plan for Directors, as amended (the "Plan") track WOR common shares on a one-for-one basis. F3: Prior to October 1, 2014, the account balances related to the phantom stock investment option could be immediately transferred to other deemed investment options under the terms of the Plan. The Plan provides that, effective October 1, 2014 and thereafter, any amount credited in a participant's account to the phantom stock fund may not be transferred to an alternative deemed investment option under the Plan until distribution from the Plan. Distributions are made only in WOR common shares and generally commence upon leaving the Board of Directors of Worthington Enterprises, Inc. F4: The amount shown reflects additional theoretical common shares (i.e., phantom stock) which were credited pursuant to the dividend reinvestment feature of the 2005 Director Deferred Compensation Plan since the date on which the amount of theoretical common shares credited pursuant to the dividend reinvestment feature under the 2005 Director Deferred Compensation Plan was last updated in the reporting person's Form 4 filed on September 24, 2025. |
| Common SharesSEC Table I · non-derivative | IndirectBy Cameron Taff Anderson Separate Trust | 1,421 |
Reported balance
Holding disclosure · report date 2025-09-23 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,421 |
| Common SharesSEC Table I · non-derivative | IndirectBy Alexa M. Anderson Separate Trust | 1,421 |
Reported balance
Holding disclosure · report date 2025-09-23 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,421 |
| Common SharesSEC Table I · non-derivative | IndirectBy spouse | 436 |
Reported balance
Holding disclosure · report date 2025-09-23 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 436 |
Filing footnotes · ownership attribution and instrument terms
F1: An award of restricted stock was granted pursuant to the Worthington Enterprises, Inc. 2025 Equity Plan for Non-Employee Directors. The restricted stock will vest on the earlier to occur of (1) the first anniversary of the grant date; or (2) the date on which the next Annual Meeting of Shareholders of Worthington Enterprises, Inc. is held.
F2: The theoretical WOR common shares ("phantom stock") credited to the reporting person's account in the Worthington Industries, Inc. Amended and Restated 2005 Deferred Compensation Plan for Directors, as amended (the "Plan") track WOR common shares on a one-for-one basis.
F3: Prior to October 1, 2014, the account balances related to the phantom stock investment option could be immediately transferred to other deemed investment options under the terms of the Plan. The Plan provides that, effective October 1, 2014 and thereafter, any amount credited in a participant's account to the phantom stock fund may not be transferred to an alternative deemed investment option under the Plan until distribution from the Plan. Distributions are made only in WOR common shares and generally commence upon leaving the Board of Directors of Worthington Enterprises, Inc.
F4: The amount shown reflects additional theoretical common shares (i.e., phantom stock) which were credited pursuant to the dividend reinvestment feature of the 2005 Director Deferred Compensation Plan since the date on which the amount of theoretical common shares credited pursuant to the dividend reinvestment feature under the 2005 Director Deferred Compensation Plan was last updated in the reporting person's Form 4 filed on September 24, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2024 Filed Jun 12, 2024 21:14 UTC | ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 | Exercise / conversionRestricted Stock Unit · Derivative | 4,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-006768 · doc4.xml · derivative · entry 2 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,292 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders. F2 · derivative.expiration_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 21:14 UTC | ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 | Exercise / conversionClass A Common Stock | 4,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-006768 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:00 UTC | ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 | SaleClass A Common Stock | 3,400 | $173.01 | $588,234.00 |
DisclosureSEC source: 0001225208-24-006603 · doc4.xml · nonDerivative · entry 4 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,378 F4 · price: Price represents a weighted average of the sale price. Shares were sold at prices ranging from $172.53 to $173.26. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting personwill provide the full information about the number of shares sold at each separate price. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:00 UTC | ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 | SaleClass A Common Stock | 2,100 | $173.92 | $365,232.00 |
DisclosureSEC source: 0001225208-24-006603 · doc4.xml · nonDerivative · entry 3 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,778 F3 · price: Price represents a weighted average of the sale price. Shares were sold at prices ranging from $173.69 to $174.19. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting personwill provide the full information about the number of shares sold at each separate price. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:00 UTC | ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 | SaleClass A Common Stock | 1,100 | $170.39 | $187,429.00 |
DisclosureSEC source: 0001225208-24-006603 · doc4.xml · nonDerivative · entry 2 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,878 F2 · price: Price represents a weighted average of the sale price. Shares were sold at prices ranging from $170.14 to $170.44. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting personwill provide the full information about the number of shares sold at each separate price. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:00 UTC | ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 | SaleClass A Common Stock | 900 | $171.67 | $154,503.00 |
DisclosureSEC source: 0001225208-24-006603 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,978 F1 · price: Price represents a weighted average of the sale price. Shares were sold at prices ranging from $171.50 to $172.12. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting personwill provide the full information about the number of shares sold at each separate price. Read SEC document |
| May 02, 2024 Filed May 2, 2024 20:29 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 250 | $200.10 | $50,024.53 |
DisclosureSEC source: 0001127602-24-013993 · form4.xml · nonDerivative · entry 2 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,722 Read SEC document |
| April 30, 2024 Filed May 2, 2024 20:29 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 250 | $204.14 | $51,033.75 |
DisclosureSEC source: 0001127602-24-013993 · form4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,972 Read SEC document |
| April 05, 2024 Filed Apr 9, 2024 20:56 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GrantCommon Stock | 30.16 | $331.56 | $9,999.85 |
DisclosureSEC source: 0000089800-24-000079 · wk-form4_1712696188.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Fee Plan Disclosed balance after: 790.45 F1 · shares: Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company. F2 · price: Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account. F3 · balance_after: These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:55 UTC | ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 | SaleClass A Common Stock | 2,770 | $127.30 | $352,621.00 |
DisclosureSEC source: 0001225208-24-004077 · doc4.xml · nonDerivative · entry 2 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,878 F1 · price: Price represents a weighted average of the sale price. Shares were sold at prices ranging from $126.67 to $127.65. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting personwill provide the full information about the number of shares sold at each separate price. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:55 UTC | ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 | SaleClass A Common Stock | 230 | $127.75 | $29,382.50 |
DisclosureSEC source: 0001225208-24-004077 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,648 Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 00:14 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GrantCommon Stock | 594 | $0.00 | $0.00 |
DisclosureSEC source: 0000089800-24-000015 · wk-form4_1708042467.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,744 F1 · kind: Grant of restricted stock units ("RSUs") under The Sherwin-Williams Company 2006 Stock Plan for Nonemployee Directors. F2 · balance_after: These securities consist of 1,244 RSUs and 3,500 shares of common stock. Each RSU represents the Reporting Person's right to receive one share of common stock. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 17:42 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 947 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-003884 · form4.xml · derivative · entry 5 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 944 Underlying: Common Stock · 947 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vested fully on February 7, 2024. F4 · derivative.expiration_date: The Restricted Stock Units vested fully on February 7, 2024. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 17:42 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 947 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-003884 · form4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 17:42 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 944 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-003884 · form4.xml · derivative · entry 4 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,891 Underlying: Common Stock · 944 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 6, 2025. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 6, 2025. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Amount includes an additional 98 Restricted Stock Units resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Laboratory Corporation of America Holdings and Fortrea Holdings Inc. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:50 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GrantCommon Stock | 33.67 | $296.96 | $9,998.64 |
DisclosureSEC source: 0000089800-24-000002 · wk-form4_1704837039.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Fee Plan Disclosed balance after: 758.72 F1 · kind: Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company. F2 · price: Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account. F3 · balance_after: These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan. Read SEC document |
| October 06, 2023 Filed Oct 10, 2023 12:44 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GrantCommon Stock | 38.27 | $253.15 | $9,688.05 |
DisclosureSEC source: 0001209191-23-052406 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Plan Disclosed balance after: 723.54 F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement. F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan. Read SEC document |
| September 29, 2023 Filed Oct 2, 2023 18:30 UTC | WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 | GrantCommon Shares | 2,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-050989 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,715 F1 · shares: An award of restricted stock was granted pursuant to the Worthington Industries, Inc. Amended and Restated 2006 Equity Incentive Plan for Non-Employee Directors. The restricted stock will vest on the earlier to occur of (1) the first anniversary of the grant date (September 29, 2024); or (2) the date on which the next Annual Meeting of Shareholders of Worthington Industries, Inc. is held. Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 12:55 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 5,000 | $211.57 | $1,057,832.50 |
DisclosureSEC source: 0001127602-23-022267 · form4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,275 Read SEC document |
| August 07, 2023 Filed Aug 8, 2023 13:34 UTC | WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 | SaleCommon Shares | 5,000 | $72.00 | $359,980.00 |
DisclosureSEC source: 0001209191-23-044905 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,415 Read SEC document |
| July 07, 2023 Filed Jul 10, 2023 17:44 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GrantCommon Stock | 37.7 | $257.00 | $9,688.90 |
DisclosureSEC source: 0001209191-23-041889 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Plan Disclosed balance after: 683.75 F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement. F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 20:10 UTC | ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 | Exercise / conversionRestricted Stock Unit · Derivative | 7,565 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-006720 · doc4.xml · derivative · entry 3 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,292 Underlying: Class A Common Stock · 7,565 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders. F2 · derivative.expiration_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 20:10 UTC | ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 | GrantRestricted Stock Unit · Derivative | 4,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-006720 · doc4.xml · derivative · entry 2 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,857 Underlying: Class A Common Stock · 4,292 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders. F2 · derivative.expiration_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 20:10 UTC | ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 | Exercise / conversionClass A Common Stock | 7,565 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-006720 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 19:33 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GrantCommon Stock | 43.31 | $223.68 | $9,687.58 |
DisclosureSEC source: 0001209191-23-024067 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Deferred Plan Disclosed balance after: 644.43 F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement. F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:49 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GrantCommon Stock | 711 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-010104 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,150 F1 · kind: Grant of restricted stock units under The Sherwin-Williams Company 2006 Stock Plan for Nonemployee Directors. F2 · balance_after: Of shares listed, 1,558 are restricted stock units. Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 20:22 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 742 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005113 · form4.xml · derivative · entry 4 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 849 Underlying: Common Stock · 742 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 11, 2023. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 11, 2023. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 20:22 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 742 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-005113 · form4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 17:10 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 849 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-004121 · form4.xml · derivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,591 Underlying: Common Stock · 849 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 7, 2024. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 7, 2024. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 21:22 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GrantCommon Stock | 41.64 | $232.66 | $9,687.96 |
DisclosureSEC source: 0001209191-23-002781 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Plan Disclosed balance after: 599.45 F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement. F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:39 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GrantCommon Stock | 46.26 | $209.43 | $9,688.23 |
DisclosureSEC source: 0001209191-22-053320 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Plan Disclosed balance after: 556.47 F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement. F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan. Read SEC document |
| September 28, 2022 Filed Sep 30, 2022 16:58 UTC | WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 | GrantCommon Shares | 2,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-051598 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,415 F1 · shares: An award of restricted stock was granted pursuant to the Worthington Industries, Inc. Amended and Restated 2006 Equity Incentive Plan for Non-Employee Directors. The restricted stock will vest on the earlier to occur of (1) the first anniversary of the grant date (September 28, 2023); or (2) the date on which the next Annual Meeting of Shareholders of Worthington Industries, Inc. is held. Read SEC document |
| July 08, 2022 Filed Jul 12, 2022 18:06 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GrantCommon Stock | 40.72 | $237.91 | $9,687.70 |
DisclosureSEC source: 0001209191-22-041873 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Plan Disclosed balance after: 508.95 F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement. F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 20:13 UTC | ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 | Exercise / conversionRestricted Stock Unit · Derivative | 3,615 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-007926 · doc4.xml · derivative · entry 4 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,565 Underlying: Class A Common Stock · 3,615 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F5 · derivative.exercise_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders. F5 · derivative.expiration_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 20:13 UTC | ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 | GrantRestricted Stock Unit · Derivative | 7,565 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-007926 · doc4.xml · derivative · entry 3 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,180 Underlying: Class A Common Stock · 7,565 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F5 · derivative.exercise_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders. F5 · derivative.expiration_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 20:13 UTC | ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 | Exercise / conversionPhantom Stock · Derivative | 904 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-007926 · doc4.xml · derivative · entry 2 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,055 Underlying: Class A Common Stock · 904 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director. F3 · balance_after: Total includes accrued dividends. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 20:13 UTC | ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 | Exercise / conversionClass A Common Stock | 2,711 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-007926 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 18:47 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GrantCommon Stock | 36.61 | $264.59 | $9,686.64 |
DisclosureSEC source: 0001209191-22-024099 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Plan Disclosed balance after: 467.73 F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement. F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 16:55 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GrantCommon Stock | 529 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-010543 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,439 F1 · kind: Grant of restricted stock units under The Sherwin-Williams Company 2006 Stock Plan for Nonemployee Directors. F2 · balance_after: Of shares listed, 1,618 are restricted stock units. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 17:35 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 742 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004959 · form4.xml · derivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 742 Underlying: Common Stock · 742 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 11, 2023. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 11, 2023. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 21:16 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 771 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-003369 · form4.xml · derivative · entry 8 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 771 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vested fully on February 2, 2022. F4 · derivative.expiration_date: The Restricted Stock Units vested fully on February 2, 2022. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 21:16 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 771 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-003369 · form4.xml · nonDerivative · entry 4 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 17:07 UTC | ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 | GrantPhantom Stock · Derivative | 202 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-001273 · doc4.xml · derivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,151 Underlying: Class A Common Stock · 202 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director. F3 · balance_after: Total includes accrued dividends. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 17:26 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GrantCommon Stock | 29.54 | $327.94 | $9,687.35 |
DisclosureSEC source: 0001209191-22-002810 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Plan Disclosed balance after: 430.04 F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement. F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 14:47 UTC | WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 | GiftCommon Shares | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070886 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,715 F1 · shares: This is a voluntary filing to disclose a transaction involving a gift of securities by the Reporting Person to a charity. Read SEC document |
| December 14, 2021 Filed Feb 4, 2022 21:16 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GiftCommon Stock | 860 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-003369 · form4.xml · nonDerivative · entry 3 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,762 Read SEC document |
| December 14, 2021 Filed Feb 4, 2022 21:16 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GiftCommon Stock | 345 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-003369 · form4.xml · nonDerivative · entry 2 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,622 Read SEC document |
| December 14, 2021 Filed Feb 4, 2022 21:16 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GiftCommon Stock | 345 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-003369 · form4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,967 F1 · balance_after: Amount reflects annuity payment of 432 shares made by the reporting person's grantor retained annuity trust to the reporting person on September 2, 2021. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:26 UTC | ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 | GrantPhantom Stock · Derivative | 186 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-013529 · doc4.xml · derivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,949 Underlying: Class A Common Stock · 186 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director. F3 · balance_after: Total includes accrued dividends. Read SEC document |
| October 08, 2021 Filed Oct 13, 2021 22:40 UTC | SHERWIN WILLIAMS CO SHW · Entity 2948 | GrantCommon Stock | 31.74 | $291.45 | $9,250.62 |
DisclosureSEC source: 0001209191-21-060390 · doc4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Plan Disclosed balance after: 399.86 F1 · kind: Represents the number of phantom stock units acquired by the reporting person (in an exempt transaction) under the 2005 Director Deferred Fee Plan. Each phantom stock unit is the economic equivalent of one share of common stock. The phantom stock units become payable solely in stock generally upon the reporting person's retirement. F2 · balance_after: Phantom stock units listed are held pursuant to the 2005 Director Deferred Fee Plan, which includes phantom stock units acquired pursuant to the dividend reinvestment feature of such plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.